Literature DB >> 12631080

Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension.

Edilia Tapia1, Martha Franco, Laura G Sánchez-Lozada, Virgilia Soto, Carmen Avila-Casado, José Santamaría, Yasmir Quiroz, Bernardo Rodríguez-Iturbe, Jaime Herrera-Acosta.   

Abstract

BACKGROUND: Although renal protective effect of interrupting the inflammatory process is well established, it is still controversial if it also prevents the glomerular hemodynamic disturbances that initiate renal injury. We investigated the effects of suppressing inflammation with mycophenolate mofetil (MMF) on glomerular hemodynamics, arteriolar structural changes, and renal histologic injury in rats with subtotal renal ablation
METHODS: Micropuncture studies were performed 30 days after 5/6 nephrectomy in rats untreated and treated with MMF (30 mg/kg/day). Renal histology, immunohistochemistry for lymphocytes, macrophages and inducible nitric oxide synthase (iNOS) expression, as well as afferent arteriolar (AA) morphometry was evaluated.
RESULTS: Renal ablation significantly increased proteinuria (6.8 to 82.7 mg/day), mean arterial pressure (MAP) (120 to 166 mm Hg), single-nephron glomerular filtration rate (SNGFR) (34.8 to 56.3 nL/min), glomerular plasma flow (QA) (117.7 to 246.9 nL/min), and glomerular capillary pressure (PGC) (48.9 to 61.0 mm Hg). Afferent resistance (AR), efferent resistance, and ultrafiltration coefficient remained unchanged. Despite persisting arterial hypertension (152 mm Hg), MMF prevented proteinuria (13.3 mg/day), and significantly reduced SNGFR (44.4 nL/min), PGC (49.1 mm Hg), and QA (163.2 nL/min) due to a rise in AR (3.13 vs. 2.18 1010 dyn/sec/cm-5). Glomerular sclerosis, tubulointerstitial damage, lymphocyte and macrophage infiltration, and iNOS expression were significantly reduced by MMF, in addition hypertrophy of AA resistance evaluated by the media/lumen ratio was prevented (P < 0.001).
CONCLUSIONS: Reduction in proteinuria, SNGFR, QA, and PGC, despite elevated MAP, indicate preservation of AA function. These results suggest that inflammation associated arteriolopathy of AA contributes to glomerular hemodynamic disturbances that participate in the progression of renal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631080     DOI: 10.1046/j.1523-1755.2003.00811.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Pathogenesis of essential hypertension: historical paradigms and modern insights.

Authors:  Richard J Johnson; Dan I Feig; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

3.  Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats.

Authors:  Hong-Feng Zhang; Yan-Li Wang; Cheng Gao; Yan-Ting Gu; Jian Huang; Jin-Hui Wang; Jia-Hong Wang; Zhou Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-05-23       Impact factor: 6.150

4.  Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Niu Tian; Alan D Penman; R Davis Manning; Michael F Flessner; Anthony R Mawson
Journal:  J Am Soc Hypertens       Date:  2011-11-03

5.  The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase.

Authors:  Maria Pia Dell'Oglio; Gianluigi Zaza; Michele Rossini; Chiara Divella; Paola Pontrelli; Raffaella Verrienti; Monica Rutigliano; Pasquale Ditonno; Patrizia Stifanelli; Nicola Ancona; Francesco Paolo Schena; Giuseppe Grandaliano
Journal:  J Am Soc Nephrol       Date:  2010-09-23       Impact factor: 10.121

Review 6.  Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?

Authors:  Britta Höcker; Burkhard Tönshoff
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

Review 7.  Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.

Authors:  Britta Höcker; Burkhard Tönshoff
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

8.  Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.

Authors:  Edilia Tapia; Magdalena Cristóbal; Fernando E García-Arroyo; Virgilia Soto; Fabiola Monroy-Sánchez; Ursino Pacheco; Miguel A Lanaspa; Carlos A Roncal-Jiménez; David Cruz-Robles; Takuji Ishimoto; Magdalena Madero; Richard J Johnson; Laura-Gabriela Sánchez-Lozada
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-09

9.  Treatment with pyrrolidine dithiocarbamate improves proteinuria, oxidative stress, and glomerular hypertension in overload proteinuria.

Authors:  Edilia Tapia; Dolores J Sánchez-González; Omar N Medina-Campos; Virgilia Soto; Carmen Avila-Casado; Claudia M Martínez-Martínez; Richard J Johnson; Bernardo Rodríguez-Iturbe; José Pedraza-Chaverrí; Martha Franco; Laura G Sánchez-Lozada
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

Review 10.  Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.

Authors:  Agnes Hackl; Rasmus Ehren; Lutz Thorsten Weber
Journal:  Pediatr Nephrol       Date:  2016-06-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.